ABCC1 and ovarian cancer: Acute exposure to tunicamycin alters the glycosylation of MRP1 and MRP4 and increases the resistance to oxaliplatin in ovarian cancer cells, but under these conditions MRP4 is apparently the prominent player in chemoresistance [26].